— Know what they know.
Not Investment Advice

NNRX OTC

Nutranomics, Inc.
1W: +0.0% 1M: +4900.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -50.0% 5Y: -66.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 51 · $816232 mcap · 4.19B float · 0.0093% daily turnover

Balance Sheet Trends

Total Assets
$18M +9.0% ▲
5Y CAGR: +101.0%
Total Liabilities
$29M +47.8% ▲
5Y CAGR: +71.6%
Shareholders Equity
-$11M -277.6% ▼
Cash & Investments
$345K +3.6% ▲
5Y CAGR: +34.2%
Total Debt
$15M -1.9% ▼
5Y CAGR: +76.6%
Net Debt
$19M +31.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2015FY2019FY2020FY2021FY2022
— Assets —
Cash$90K$739$1K$333K$345K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$90K$739$1K$333K$345K
Net Receivables$84K$0$0$182K$1M
Inventory$123K$0$0$1M$1M
Other Current Assets$128K$0$0$0$0
Total Current Assets$433K$26K$26K$2M$3M
Property, Plant & Equip.$10K$0$0$15M$15M
Goodwill & Intangibles$4K$4K$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$2K-$0$0$0$0
Total Non-Current Assets$16K$4K$0$15M$15M
Total Assets$449K$29K$26K$17M$18M
— Liabilities —
Accounts Payable$611K$527K$551K$16K$1M
Short-Term Debt$737K$2M$2M$6M$6M
Deferred Revenue$228K$0$0$0$0
Other Current Liabilities$181K$4M$5M-$15K$8M
Total Current Liabilities$2M$6M$7M$6M$15M
Long-Term Debt$147K$0$0$0$160K
Other Non-Current Liab.$0$0$0$4M$4M
Total Non-Current Liabilities$147K$0$0$13M$13M
Total Liabilities$2M$6M$7M$19M$29M
— Equity —
Common Stock$252K$2M$4M$0$1M
Retained Earnings-$6M-$11M-$12M-$3M-$10M
Accumulated OCI$0$0-$4M$0-$1M
Total Stockholders Equity-$1M-$6M-$7M-$3M-$11M
Total Liabilities & Equity$449K$29K$26K$17M$18M
— Key Metrics —
Total Debt$884K$2M$2M$15M$15M
Net Debt$794K$2M$2M$15M$19M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms